1. The past time-series ILI occurrences over the 5 weeks displayed a relatively stable pattern with fluctuations, showing values of ['11487', '11116', '11730', '11738', '11489']. There was a slight initial decline from 11487 (Week 38, 2021) to 11116 (Week 39, 2021), followed by an increase to 11730 (Week 40, 2021) and 11738 (Week 41, 2021), before a minor dip to 11489 (Week 42, 2021). Overall, this pattern suggests a stable trend in ILI activity with periodic variations across the observed period.  

2. A correlation between past and future occurrences is evident, as the stability in ILI activity during the 5 weeks (Weeks 38–42, 2021) likely laid the foundation for the increase to 15058 occurrences after 5 weeks (Week 47, 2021). This rise indicates a potential lag in the impact of earlier stable or rising trends, combined with external contributing factors.  

3. Several factors from the summarized CDC reports correlate with the future increase in ILI occurrences. First, persistent PIC mortality remained significantly above epidemic thresholds throughout Weeks 38–42, 2021, with values ranging from 20.9% (Week 38) to 16.5% (Week 42). This reflects underlying respiratory illness activity conducive to ILI escalation. Second, changes in healthcare-seeking behaviors due to COVID-19, documented across all weeks, complicate data interpretation and likely masked or delayed ILI case surges, potentially contributing to the spike in future occurrences. Third, co-circulation of non-influenza respiratory pathogens, consistently noted across all weeks, suggests that other viruses may have enhanced respiratory illness activity during the observed period, influencing the future increase. Fourth, the ongoing limited influenza vaccination coverage reported across Weeks 38–42, 2021, may have left populations vulnerable to broader respiratory illnesses, amplifying ILI activity in later weeks.  

4. In summary, the reported 15058 future ILI occurrences (Week 47, 2021) can be attributed to the stable yet fluctuating ILI trends in Weeks 38–42, 2021, persistent PIC mortality above epidemic thresholds, the complicating effects of pandemic-driven healthcare-seeking behavior shifts, co-circulation of non-influenza respiratory pathogens, and limited influenza vaccination coverage during the observed period. These factors collectively contributed to the sharp rise in ILI occurrences after 5 weeks.  